Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandru Burlacu

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Maedica|October 7, 2011
Dupuytren's contracture: a new perspective on treatmentAlexandru Burlacu
Cureus|November 25, 2024
Percutaneous Revascularization in End-Stage Kidney Disease (ESKD) Patients With Non-culprit Coronary Stenosis: A Strategy Beyond Fractional Flow ReserveAlexandru Burlacu, Adrian Covic
Journal of Clinical Ultrasound : JCU|May 6, 2022
Left atrial functional changes as emerging diagnostic and prognostic markerMariana Floria, Alexandru Burlacu
Journal of Clinical Medicine|August 26, 2023
Special Issue: "Cardiovascular Complications in Renal Diseases"Alexandru Burlacu, Adrian Covic
International Journal of Cardiology|May 1, 2018
'Some doors are better left closed': Using LAA occluders as an alternative to warfarin in very high-risk dialysed patients with atrial fibrillationAlexandru Burlacu, Adrian Covic
Journal of the American College of Cardiology|July 18, 2020
The Devil Is in the Details When Considering the OAC Efficacy-Safety Equation in Dialysis PatientsAlexandru Burlacu, Adrian Covic
Clinical Kidney Journal|October 30, 2020
Longer or shorter dual antiplatelet therapy in dialysis patients receiving a coronary drug-eluting stent? A rope game still ongoingAlexandru Burlacu, Adrian Covic
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 21, 2021
Thrombotic Events in COVID-19: Inquires About the Deleterious Procoagulant Effect of Corticosteroid TherapyRadu Crisan-Dabija, Alexandru Burlacu
Cardiovascular Drugs and Therapy|September 7, 2018
A Narrative Review on Thrombolytics in Advanced CKD: Is it an Evidence-Based Therapy?Alexandru Burlacu, Bogdan Artene, Adrian Covic
Current Opinion in Nephrology and Hypertension|April 23, 2025
Novel approaches in antihypertensive pharmacotherapeuticsSidar Copur, Alexandru Burlacu, Mehmet Kanbay
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Maedica|October 7, 2011
Dupuytren's contracture: a new perspective on treatmentAlexandru Burlacu
Cureus|November 25, 2024
Percutaneous Revascularization in End-Stage Kidney Disease (ESKD) Patients With Non-culprit Coronary Stenosis: A Strategy Beyond Fractional Flow ReserveAlexandru Burlacu, Adrian Covic
Journal of Clinical Ultrasound : JCU|May 6, 2022
Left atrial functional changes as emerging diagnostic and prognostic markerMariana Floria, Alexandru Burlacu
Journal of Clinical Medicine|August 26, 2023
Special Issue: "Cardiovascular Complications in Renal Diseases"Alexandru Burlacu, Adrian Covic
International Journal of Cardiology|May 1, 2018
'Some doors are better left closed': Using LAA occluders as an alternative to warfarin in very high-risk dialysed patients with atrial fibrillationAlexandru Burlacu, Adrian Covic
Journal of the American College of Cardiology|July 18, 2020
The Devil Is in the Details When Considering the OAC Efficacy-Safety Equation in Dialysis PatientsAlexandru Burlacu, Adrian Covic
Clinical Kidney Journal|October 30, 2020
Longer or shorter dual antiplatelet therapy in dialysis patients receiving a coronary drug-eluting stent? A rope game still ongoingAlexandru Burlacu, Adrian Covic
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 21, 2021
Thrombotic Events in COVID-19: Inquires About the Deleterious Procoagulant Effect of Corticosteroid TherapyRadu Crisan-Dabija, Alexandru Burlacu
Cardiovascular Drugs and Therapy|September 7, 2018
A Narrative Review on Thrombolytics in Advanced CKD: Is it an Evidence-Based Therapy?Alexandru Burlacu, Bogdan Artene, Adrian Covic
Current Opinion in Nephrology and Hypertension|April 23, 2025
Novel approaches in antihypertensive pharmacotherapeuticsSidar Copur, Alexandru Burlacu, Mehmet Kanbay
Pageof 12